期刊文献+

线粒体乙醛脱氢酶2对β淀粉样蛋白所致神经元损伤的作用及机制 被引量:1

Effects and mechanism of mitochondrial aldehyde dehydrogenase 2 on neuronal damage caused by amyloid
下载PDF
导出
摘要 目的探讨线粒体乙醛脱氢酶(ALDH)2对β淀粉样蛋白(Aβ)所致神经元损伤的作用及机制。方法应用HT-22小鼠海马神经元细胞系,MTT法检测明确Aβ25~35负载浓度制成Aβ神经元损伤模型;ALDH2激活剂Alda-1、ALDH2抑制剂Daidzin干预后,Western印迹检测ALDH2蛋白表达水平;并采用ELISA检测4-HNE含量、以荧光素酶法检测细胞内的ATP含量。结果 HT22细胞负载Aβ25~35(浓度50μmol/L)时细胞生存率有显著降低;ALDH2激活剂Alda-1、ALDH2抑制剂Daidzin干预后,ALDH2蛋白表达水平并未发生变化,也并未导致细胞生存率改变;加入Alad-1后负载Aβ25~35的HT22细胞4-HNE含量显著减少,细胞内ATP含量明显提高,与Aβ组相比较有显著差异(P<0.05)。结论 ALDH2激活后能有效减轻Aβ导致的神经元损伤,可能通过减少细胞内4-HNE含量、增加ATP含量实现其细胞保护的作用。 Objective To investigate the role of mitochondrial aldehyde dehydrogenase 2( ALDH2) on neuronal damage induced byβ-amyloid( Aβ).Methods HT-22 mouse hippocampal neuronal cell line was used,MTT was used to determine Aβ concentration.Western bolt was used to detect ALDH2 protein level,ELISA was used to detect 4-HNE content,luciferase enzyme was used to detect intracellular ATP content.Results The cell survival rate was significantly decreased when HT22 cells loaded with 50 μmol / L Aβ25 ~ 35.The expression level of ALDH2 protein and the cell survival rate of HT22 did not change when intervened by ALDH2 activator Alda-1 and the inhibitor Daidzin,further experimental results showed that Alad-1 could improve the increased 4-HNE content and the reduced ATP in HT22 when cells loaded Aβ25 ~ 35.Conclusions ALDH2 activation might elicit neuronal protective effect against Aβ25 ~ 35 through reducing 4-HNE levels and increasing ATP content of the intracellular.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2015年第5期1309-1311,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金(No.81271449 81471409)
关键词 阿尔茨海默病 线粒体乙醛脱氢酶2 Β淀粉样蛋白 Alzheimer’s disease Mitochondrial aldehyde dehydrogenase 2 β-amyloid
  • 相关文献

参考文献14

  • 1Fabio Di Domenico,Gilda Pupo,Antonella Tramutola,Alessandra Giorgi,Maria Eugenia Schininà,Raffaella Coccia,Elizabeth Head,D. Allan Butterfield,Marzia Perluigi.Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease[J]. Free Radical Biology and Medicine . 2014
  • 2Si-Hai Fu,Hong-Feng Zhang,Zhong-Bao Yang,Ting-Bo Li,Bin Liu,Zheng Lou,Qi-Lin Ma,Xiu-Ju Luo,Jun Peng.Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes[J]. Naunyn-Schmiedeberg’s Archives of Pharmacology . 2014 (1)
  • 3Brian C. Jackson,Roger S. Holmes,Donald S. Backos,Philip Reigan,David C. Thompson,Vasilis Vasiliou.Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2[J]. Chemico-Biological Interactions . 2012
  • 4Jan Versijpt.Pharmacoeconomics of Alzheimer’s disease (AD) treatment with cholinesterase inhibitors[J]. Acta Neurologica Belgica . 2012 (2)
  • 5Mostofa Jamal,Kiyoshi Ameno,Takanori Miki,Weihuan Wang,Mitsuru Kumihashi,Toyohi Isse,Toshihiro Kawamoto,Kyoko Kitagawa,Keiichi Nakayama,Iwao Ijiri,Hiroshi Kinoshita.Cholinergic alterations following alcohol exposure in the frontal cortex of Aldh2-deficient mice models[J]. Brain Research . 2009
  • 6Sirui Zhou,Huriletemuer,Jing Wang,Chunyu zhang,Shigang Zhao,De Sheng Wang,Binbin Wang,Xu Ma.Absence of association on aldehyde dehydrogenase 2 ( ALDH2 ) polymorphism with Mongolian Alzheimer patients[J]. Neuroscience Letters . 2009 (3)
  • 7Hardas SS,Sultana R,Clark AM, et al.Oxidative modification of lipoic acid by HNE inAlzheimer disease brain. Redox Biol . 2013
  • 8Oyama T,Nagayoshi H,Matsuda T,et al.Effects of acetaldehydeinhalation in mitochondrial aldehyde dehydrogenase deficient mice (Aldh2-/-). Front Biosci (Elite Ed) . 2010
  • 9Jin-Min Guo,Ai-Jun Liu,Pu Zang,Wen-Zhe Dong,Li Ying,Wei W ang,Pu Xu,Xu-Rui Song,Jun Cai,She-Qing Zhang,Jun-Li Duan,Jawahar L Mehta,Ding-Feng Su.ALDH2 protects against stroke by clearing 4-HNE[J].Cell Research,2013,23(7):915-930. 被引量:21
  • 10Yoshihara Tatsuya,Sasaguri Toshiyuki.[ALDH2 polymorphisms and clinical medicine]. Fukuoka igaku zasshi = Hukuoka acta medica . 2012

二级参考文献14

  • 1Traylor M, Farrall M, Holliday EG, et al. Lancet Neurol 2012; 11:951–962. | Article | PubMed |.
  • 2Bevan S, Traylor M, Adib-Samii P, et al. Stroke 2012; 43:3161–3167. | Article | PubMed |.
  • 3Manolio TA, Collins FS, Cox NJ, et al. Nature 2009; 461:747–753. | Article | PubMed | ISI | CAS |.
  • 4Gretarsdottir S, Thorleifsson G, Manolescu A, et al. Ann Neurol 2008; 64:402–409. | Article | PubMed | ISI |.
  • 5Gudbjartsson DF, Holm H, Gretarsdottir S, et al. Nat Genet 2009; 41:876–878. | Article | PubMed | ISI | CAS |.
  • 6Guo JM, Liu AJ, Zang P, et al. Cell Res 2013; 23:915–930. | Article |.
  • 7Peng GS, Yin SJ. Hum Genomics 2009; 3:121–127. | Article | PubMed |.
  • 8Kato N, Takeuchi F, Tabara Y, et al. Nat Genet 2011; 43:531–538. | Article | PubMed | CAS |.
  • 9Doser TA, Turdi S, Thomas DP, et al. Circulation 2009; 119:1941–1949. | Article | PubMed |.
  • 10Koda K, Salazar-Rodriguez M, Corti F, et al. Circulation 2010; 122:771–781. | Article | PubMed | ISI | CAS |.

共引文献23

同被引文献3

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部